Register Login

Ottawa Blood Disease Center DOAC Survey

George is posting this survey invitation as a courtesy to the Ottawa Blood Disease center and encourages all physician Fritsma Factor participants to join the survey:


 You are being asked to participate in a research survey* that we have developed. Physician members from a variety of associations in Canada, the United States and Europe will be asked to participate. The questions from this survey* pertain to the management of bleeding complications in the setting of direct oral anticoagulant (DOAC) use. The survey* will take approximately 10 minutes to complete, and will include questions regarding demographic information, knowledge of DOAC pharmacokinetics and laboratory assessment of DOAC anticoagulation status, knowledge surrounding the assessment and management of DOAC-associated life-threatening bleeding, as well as opinions surrounding DOAC-associated life-threatening bleeding.

The entire study will last approximately 5 months. Your participation in the study will end after you have completed the survey. You might find the survey tiring. You do not have to answer any questions that make you uncomfortable. Your participation in this study is voluntary. The alternative to this study is not to participate. All the information is anonymous. You can withdraw from the study at any time however, once you have submitted the survey, the information cannot be removed. All study-related information will be kept for 10 years after termination of study.

The Ottawa Health Science Network (OHSN-REB) and the Ottawa Hospital Research Institute may review the original study records. The Ottawa Health Science Network Research Ethics Board (OHSN-REB) has reviewed the plans for this research study. The Board considers the ethical aspects of all research studies involving human participants at the Ottawa Hospital. If you have any questions about your rights as a research participant, you may contact the Chairperson at 613-761-5555, ext. 16719. Completion of the survey implies your consent to participate in this research study.

We appreciate your time and assistance,
Marc Carrier, MD MSc FRCPC                                 Joseph R. Shaw, MD
Ottawa Blood Disease Centre                               Ottawa Blood Disease Centre
The Ottawa Hospital, General Campus              The Ottawa Hospital
501 Smyth Road, Box 201A                                     [email protected]
Ottawa, ON K1H 8L6                                                
Tel: 613-737-8899, ext. 73034

*Click or tap to participate.

Comments (0)
Anticoagulant Therapy

No comments here.

Leave a Reply